Request for Covid-19 Impact Assessment of this Report

Healthcare

Biosimilars Market in India 2017

  • NET3245822
  • 43 Pages
  • April 2017
  • Healthcare
Download Sample    Get Discount   
 
Netscribes latest market research report titled Biosimilars Market in India 2017, describes the current and forecasted dynamics of the biosimilars market in India. The increasing incidence of diseases such as CVD and CHD, cancer and diabetes has led to an increase in the demand for these products and has resulted in the growth of this industry in India. Biosimilars are typically marketed at prices that are 25% to 40% below the prices of original branded products. This has been the primary appeal to customers. Moreover, the rise in the number and quality of tertiary care centers is resulting in the greater usage of these products. Rising drug costs, limited healthcare budgets across the world and patent expiries of biotechnology drugs have created a huge opportunity for biosimilar manufacturers. There aren't too many players in the market and the industry is dominated by a small number of sellers leaving a room for the new entrants in the market.

However, required capital investment and operating costs for manufacturing is much higher for biosimilars than for generic drugs. The process to develop a generic version of biosimilar is also complex than developing a generic copy of a chemical-based compound. Extensive funding is required due to emerging rigorous regulatory requirements which act as a challenge for the players in the industry. Lack of widespread awareness towards the biosimilar products is also acting as a drawback for the industry as people tend to avoid using biosimilar products. The stringent regulatory framework of the healthcare industry which requires biosimilars to undergo several regulatory measures is cumbersome for companies looking to constantly innovate and launch new products in the market. Although there are challenges in the industry, the market for biosimilars is expected to grow with more players entering the market and development of new biosimilar products for the treatment of chronic diseases.

Slide 1: Executive Summary

Socioeconomic Indicators

Slide 2: Total Population (2010-2011 – 2019-2020), Population Density (2010-2011 – 2019-2020)

Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011 – 2019-2020)

Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020)

Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011)

Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014)

Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015)

Market Overview

Slide 8: Market Definition and Structure

Slide 9: Biosimilars Market in India – Overview, Size and Growth (Value-Wise, 2011 – 2020e)

Slide 10: Regulatory Bodies and Guidelines

Market Opportunity

Slide 11: Future Growth Opportunities for the Market

Market Influencers

Slide 12: Market Drivers

Slide 13: Market Challenges

Competitive Landscape

Slide 14: List of Major Players

Slide 15-36: Profiles of Major Players

Recent Developments

Slide 37-42: Key Recent Developments

Appendix

Slide 43: Research Methodology

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950